ABL Diagnostics (FR001400AHX6 – ABLD, the“Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Genient Tech Private Ltd. ( ).

Meanwhile, in the adjuvant setting, Roche has approval for its PD-L1 inhibitor Tecentriq (atezolizumab) after surgery and platinum-based chemotherapy in patients with NSCLC tumours in which 1% or ...

From beach and boating lovers, to hikers and athletes, you’ll want to keep a few of these sun protection essentials stashed ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

CD8 T cells lacking Tet1/3 preferentially differentiate into short-lived effector and effector memory cells following acute ...

Single-Molecule Footprinting reveals that RNA polymerase II (Pol II) occupancy is infrequent at mouse promoters. This results ...

According to Research by SNS Insider, The DNA Sequencing Market Growth is Driven by Technological Advancements and Rising Demand for Precision MedicineAustin, April 04, 2025 (GLOBE NEWSWIRE) -- DNA ...

The actor who plays a villain on the ‘Yellowstone’ prequel series explains how his character’s “diabolical” mission led to a “dissent into madness” for the man who would never die ...

Laboratory of Human Genetics & Therapeutics, Smart Health Initiative, Division of Biological and Environmental Science and Engineering (BESE), King Abdullah University of Science and Technology (KAUST ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...